Therapix Biosciences announces results of Phase IIa study at for Tourette syndrome program; shares ahead 35% premarket [Seeking Alpha]
THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE (TRPX)
US:NASDAQ Investor Relations:
nasdaq.com/symbol/trpx
Company Research
Source: Seeking Alpha
Therapix Biosciences announces results of Phase IIa study at for Tourette syndrome program; shares ahead 35% premarketTherapix Biosciences (NASDAQ:TRPX) surges35% premarket onannouncing topline results from its investigator-initiated Phase 2a study at Yale University, suggesting that THX-110 [a combination of dronabinol (?-9-tetrahydrocannabinol) and palmitoylethanolamide (PEA)] significantly improved symptoms over time in adult Subjects with Tourette syndrome.The study enrolled 16 subjects and was followed-up for a period of 12 weeks. The primary endpoint of the study was to assess the performance of THX-110 in the treatment of adult patients, as measured by the Yale Global Tic Severity Scale Total Tic Score, (YGTSS-TTS) the gold-standard and customary index for assessing symptom severity.The study showed reduction of tic symptoms, resulting in an average tic reduction of 21% across the entire sample.In Six of the 16 subjects, reduction in YGTSS-TTS was greater than 25%. 12 subjects
Show less
Read more
Impact Snapshot
Event Time:
TRPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRPX alerts
High impacting THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE news events
Weekly update
A roundup of the hottest topics